On July 5th, 2024, Harbin Gloria Pharmaceuticals (002437.SZ) accepted a specific investigation on the question of "What is the business volume of CMO and the layout of the CDMO field?" The company responded that Pude Pharmaceuticals is a well-known injection product OEM enterprise in the north, with CMO business for more than 100 products. As these products are successively approved, launched, and sold, it is expected to contribute to the company's revenue and profit. In the future, the company's CMO business will move closer to the R&D end in order to strive for better products.

The company has entered into equity plus product cooperation with Nanjing Biomaid, and has carried out business cooperation with other CRO companies.